Human Mucin-1 / MUC-1 (1036-1155) Protein, His Tag
分子別名(Synonym)
Mucin-1,MUC-1,CD227
表達區(qū)間及表達系統(tǒng)(Source)
Human Mucin-1 (1036-1155), His Tag (MU1-H52H5) is expressed from human 293 cells (HEK293). It contains AA Leu 1036 - Gly 1155 (Accession # P15941-1).
Predicted N-terminus: Leu 1036 (partial α chain) & Ser 1098 (partial β chain)
蛋白結(jié)構(gòu)(Molecular Characterization)
This protein carries a polyhistidine tag at the C-terminus. The mature form of Mucin-1 is a non-covalent heterodimeric complex with the proteolytically cleaved partial α and partial β chain. Each partial α and partial β chain has a calculated MW of 7.2 kDa (partial α chain) and 8.2 kDa (partial β chain). The protein migrates as 13-15 kDa (partial α chain) and 10 kDa (partial β chain) under reducing (R) condition (SDS-PAGE) due to glycosylation.
內(nèi)毒素(Endotoxin)
Less than 1.0 EU per μg by the LAL method.
純度(Purity)
>90% as determined by SDS-PAGE.
制劑(Formulation)
Lyophilized from 0.22 μm filtered solution in PBS, pH7.4 with trehalose as protectant.
Contact us for customized product form or formulation.
重構(gòu)方法(Reconstitution)
Please see Certificate of Analysis for specific instructions.
For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.
存儲(Storage)
For long term storage, the product should be stored at lyophilized state at -20°C or lower.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
-20°C to -70°C for 12 months in lyophilized state;
-70°C for 3 months under sterile conditions after reconstitution.
背景(Background)
Mucin-1蛋白在上皮細胞中具有多種功能,包括細胞保護、轉(zhuǎn)移過程中的外滲、管腔結(jié)構(gòu)的維持和信號轉(zhuǎn)導(dǎo)。MUC17含有一個延伸的、重復(fù)的細胞外糖基化結(jié)構(gòu)域和一個羧基末端,具有兩個EGF樣結(jié)構(gòu)域,一個SEA模塊結(jié)構(gòu)域、一個跨膜結(jié)構(gòu)域和具有潛在絲氨酸和酪氨酸磷酸化位點的細胞質(zhì)結(jié)構(gòu)域。通過其C末端與PDZK1相互作用,這種相互作用對正確定位很重要??赡茉诰S持粘膜表面的穩(wěn)態(tài)方面發(fā)揮作用。
關(guān)鍵字: Mucin-1;Mucin-1蛋白;MUC-1重組蛋白;ACRO;百普賽斯;
百普賽斯集團ACROBiosystems Group(股票代碼:301080)是成立于2010年的跨國生物科技公司,是為全球生物醫(yī)藥、健康產(chǎn)業(yè)領(lǐng)域提供關(guān)鍵生物試劑產(chǎn)品及解決方案的行業(yè)平臺型基石企業(yè)。2021年在創(chuàng)業(yè)板上市。百普賽斯集團業(yè)務(wù)遍布全球,橫跨亞洲、北美洲、歐洲,在中國、美國、瑞士等12個城市設(shè)有辦公室、研發(fā)中心及生產(chǎn)基地。目前累計服務(wù)客戶超6000家,與全球Top 20醫(yī)藥企業(yè)均建立了長期、穩(wěn)定的合作伙伴關(guān)系。集團旗下?lián)碛衅放艫CROBiosystems百普賽斯、bioSeedin柏思薈、Condense Capital墾拓資本和ACRODiagnostics百斯醫(yī)學(xué)等。